Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation

Annals of Surgery

Volumn 231, Issue 3, 2000, Pages 387-398

  Yamakawa, Yasuhiko ^b   Takano, Manabu ^b   Patel, Mayur ^a   Tien, Nevin ^a   Takada, Tadahiro ^b   Bulkley, Gregory B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; VINBLASTINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRYSTALLOID; ENZYME ACTIVITY; LEUKOPENIA; LIVER INJURY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; RESUSCITATION; SHOCK;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; LEUKOCYTES; LIVER; MALE; OXIDATIVE STRESS; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION; REPERFUSION INJURY; RESUSCITATION; SHOCK, HEMORRHAGIC; TIME FACTORS; XANTHINE OXIDASE;

EID: 0034106862     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200003000-00012     Document Type: Article

References (63)

1. Bulkley GB, Oshima A, Bailey RW. Pathophysiology of hepatic ischemia in cardiogenic shock. Am J Surg 1986; 151:87-97.
2. Rawson JS, Achord JL. Shock liver. South Med J 1985; 78:1421-1425.
3. Champion HR, Jones RT, Trump BF, et al. A clinicopathologic study of hepatic dysfunction following shock. Surg Gynecol Obstet 1976; 142:657-663.
4. Nunes G, Blaisdell FW, Margaretten W. Mechanism of hepatic dysfunction following shock and trauma. Arch Surg 1970; 100:546-556.
5. Konishi Y, Shaked A, Egawa H, et al. Correlation of hepatic injury, synthetic function, and mitochondria energy level in orthotopic liver transplantation. J Surg Res 1992; 52:466-471.
6. Gibson PR, Dudley FJ. Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust NZ J Med 1984; 14:822-825.
7. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979; 24:129-135.
8. Birgens HS, Henriksen J, Matzen P, Poulsen H. The shock liver: clinical and biochemical findings in patients with centrilobular liver necrosis following cardiogenic shock. Acta Med Scand 1978; 204: 417-421.
9. Schiller HJ, Buchman TG, Bulkley GB. Multiple system organ failure. In: Cameron JL, ed. Current Surgical Therapy. Philadelphia: BC Decker; 1992:1067-1072.
10. Klein A, Zhadkevich M, Margolick J, et al. Quantitative discrimination of hepatic reticuloendothelial clearance and phagocytic killing. J Leukoc Biol 1994; 55:248-252.
11. Kondo S, Wang D, Mayumi T, et al. Effect of hemorrhagic shock and resuscitation upon hepatic phagocytic clearance and killing of circulating microorganisms. Shock 1996; 5:106-111.
12. Ratych RE, Chuknyiska RS, Bulkley GB. The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 1987; 102:122-131.
13. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981; 81:22-29.
14. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury to the cat small intestine: role of superoxide radicals. Gastroenterology 1982; 82:9-15.
15. Bulkley GB. Endothelial xanthine oxidase: a radical transducer of inflammatory signals for reticuloendothelial activation. Br J Surg 1993; 80:684-686.
16. Bulkley GB. Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. The Lancet 1994; 344:934-936.
17. Kubes P, Suzuki M, Granger DN. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. Am J Physiol 1990; 258:G158-G163.
18. Jaeschke H, Schini VB, Farhood A. Role of nitric oxide in the oxidant stress during ischemia/reperfusion injury of the liver. Life Sci 1992; 50:1797-1804.
19. Horie Y, Wolf R, Granger DN. Role of nitric oxide in gut ischemia-reperfusion-induced hepatic microvascular dysfunction. Am J Physiol 1997; 273:G1007-G1013.
20. Mayumi T, Chan CK, Clemens MG, Bulkley GB. Zonal heterogeneity of hepatic injury following shock/resuscitation: relationship of xanthine oxidase activity to localization of neutrophil accumulation and central lobular necrosis. Shock 1996; 5:324-332.
21. Wang P, Singh G, Rana MW, et al. Preheparinization improves organ function after hemorrhage and resuscitation. Am J Physiol 1990; 259:R645-R650.
22. Bulkley GB, Amano H, Hamilton SR, Zuidema GD. Microvascular thrombosis preventing reperfusion: a factor limiting intestinal recovery from acute ischemic injury [abstract]. Microvasc Res 1982; 245.
23. Tan S, Yokoyama Y, Dickens E, et al. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med 1993; 15:407-414.
24. Whigham H, Weil MH. A model for the study of hemorrhagic shock in the rat: development of the method. J Appl Physiol 1966; 21:1860-1863.
25. Wigger CJ. Physiology of Shock. New York: The Commonwealth Fund; 1950.
26. Grode GA, Anderson SJ, Grotta HM, Falb RD. Nonthrombogenic materials via a simple coating process. Transactions of the American Society for Artificial Internal Organs 1998; 15:1-6.
27. Belinsky SA, Popp JA, Kauffman FC, Thurman RG. Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver. J Pharmacol Exp Ther 1984; 230:755-760.
28. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502-522.
29. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106:207-212.
30. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14:157-167.
31. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78:206-209.
32. Moloney WC, McPherson K, Fliegelman L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960; 8:200-207.
33. Katayama I, Mochino T. Naphthol AS-D chloroacetate esterase reaction. Systemic modifications for optimization to smears and sections. Acta Pathol Jpn 1983; 33:381-393.
34. Amador E, Franey RJ, Massod MF. Serum glutamic-oxaloacetic transaminase activity: diagnostic accuracy of the revised spectrophotometric and the dinitrophenyl-hydrazine methods. Clin Chem 1966; 12:475-481.
35. Babson AL, Arndt EG, Sharkey LJ. A revised colorimetric glutamicoxalacetic transaminase assay. Clin Chim Acta 1969; 26:419-423.
36. Yamauchi M, Potter JJ, Mezey E. Lobular distribution of alcohol dehydrogenase in the rat liver. Hepatology 1988; 8:243-247.
37. Kato S, Ishii H, Aiso S, et al. Histochemical and immunohistochemical evidence for hepatic zone 3 distribution of alcohol dehydrogenase in rats. Hepatology 1990; 12:66-69.
38. Vickers S, Schiller HJ, Hildreth JEK, Bulkley GB. Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery 1998; 124:551-560.
39. Jaeschke H. The therapeutic potential of glutathione in hepatic ischemia-reperfusion injury. Transplantation 1993; 56:256-257.
40. Okuda M, Lee H-C, Chance B, Kumar C. Glutathione and ischemia-reperfusion injury in the perfused rat liver. Free Radic Biol Med 1992; 12:271-279.
41. Moorhouse PC, Grootveld M, Halliwell B, et al. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987; 213:23-28.
42. Zimmerman BJ, Parks DA, Grisham MB, Granger DN. Allopurinol does not enhance antioxidant properties of extracellular fluid. Am J Physiol 1988; 255:H202-H206.
43. Klein AS, Joh JW, Rangan U, et al. Allopurinol: discrimination of antioxidant from enzyme inhibitory activities. Free Radic Biol Med 1996; 21:713-717.
44. Toledo-Pereyra LH, Simmons RL, Najarian JS. Effect of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes. Ann Surg 1974; 180:780-782.
45. Kusumoto K, Morimoto T, Minor T, et al. Allopurinol effects in rat liver transplantation on recovery of energy metabolism and free radical-induced damage. Eur Surg Res 1995; 27:285-291.
46. Karwinski W, Farstad M, Ulvik R, Soreide O. Sixty-minute normothermic liver ischemia in rats. Evidence that allopurinol improves liver cell energy metabolism during reperfusion but that timing of drug administration is important. Transplantation 1991; 52:231-234.
47. Sun X, Hsueh W. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. J Immunol 1991; 147:509-514.
48. Zhang C, Hsueh W, Caplan MS, Kelly A. Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991; 19:1067-1072.
49. Hsueh W, Gonzalez-Crussi F, Arroyave JL. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987; 1:403-405.
50. Bautista AP, Spitzer JJ. Platelet activating factor stimulates and primes the liver. Kupffer cells and neutrophils to release superoxide anion. Free Rad Res Comm 1992; 17:195-209.
51. Komatsu Y, Shiratori Y, Hikiba Y, et al. Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury. Dig Dis Sci 1996; 41:1030-1037.
52. Walcher F, Marzi I, Fisher R, et al. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation. J Surg Res 1996; 61:244-249.
53. Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol 1990; 259:G859-G864.
54. Nilsson UA, Schoenberg MH, Aneman A, et al. Free radicals and pathogenesis during ischemia and reperfusion of the cat small intestine. Gastroenterology 1994; 106:629-636.
55. Hernandez LA, Granger DN. Role of antioxidants in organ preservation and transplantation. Crit Care Med 1988; 16:543-549.
56. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 1998; 9:47-71.
57. Romson JL, Hook BG, Kunkel SL, et al. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67:1016-1023.
58. Terada LS, Arnold PD. Xanthine oxidase does not mediate the antiproliferative effects of interferon-gamma in human umbilical vein endothelial cells. J Interferon Res 1998; 13:419-422.
59. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR. An in vitro model of ischemia/reperfusion-induced microvascular injury. Am J Physiol 1990; 259:G134-G139.
60. Inauen W, Granger DN, Meininger CJ, Schelling ME, Granger HJ, Kvietys PR. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol 1990; 259:H925-H931.
61. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995; 270:18966-18974.
62. Morita Y, Clemens MG, Miller LS, et al. Reactive oxidants mediate TNF-α-induced leukocyte adhesion to rat mesenteric venular endothelium. Am J Physiol 1995; 269:H1833-H1842.
63. Arai T, Kelly SA, Brengman ML, et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule-1 (ICAM-1) induction by TNF-α in endothelium. Biochem J 1998; 331:853-861.